Filing Details

Accession Number:
0000899243-23-006394
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-28 16:06:25
Reporting Period:
2023-02-24
Accepted Time:
2023-02-28 16:06:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1658551 Amylyx Pharmaceuticals Inc. AMLX () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1543112 Ltd Investments Venture Morningside 2Nd Floor, Le Prince De Galles
3-5 Avenue Des Citronniers
Monaco O9 MC 98000
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-02-22 47,888 $34.70 7,532,710 No 4 S Direct
Common Stock Disposition 2023-02-22 2,112 $35.34 7,530,598 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.25 to $35.25, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.28 to $35.45, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  3. Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.